Triple-negative breast cancer (TNBC) is a breast cancer subtype which is heterogeneous in nature and has the characteristic of negativity for estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor (EGFR or HER2). This evidence concerns the gene ESR1 and breast carcinoma.